# reload+after+2024-01-21 13:44:19.403602
address1§6714 NW 16th Street
address2§Suite B
city§Gainesville
state§FL
zip§32653
country§United States
phone§386 418 8060
fax§321 244 8351
website§https://cyclotherapeutics.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
fullTimeEmployees§9
companyOfficers§[{'maxAge': 1, 'name': 'Mr. N. Scott Fine', 'age': 66, 'title': 'CEO & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 877881, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. C. E Strattan', 'age': 77, 'title': 'Founder & Director', 'yearBorn': 1946, 'fiscalYear': 2022, 'totalPay': 44000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Joshua M. Fine', 'age': 41, 'title': 'CFO & Secretary', 'yearBorn': 1982, 'fiscalYear': 2022, 'totalPay': 509384, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael Eric Lisjak', 'age': 50, 'title': 'Chief Regulatory Officer & Senior VP of Business Development', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 505905, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jeffrey L. Tate Ph.D.', 'age': 65, 'title': 'COO, Chief Quality Officer & Director', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 255138, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Lori McKenna Gorski', 'title': 'Global Head of Patient Advocacy', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Karen  Mullen FFPM', 'title': 'Interim Chief Medical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.116
priceToSalesTrailing12Months§47.46114
currency§USD
dateShortInterest§1702598400
forwardEps§-1.05
exchange§NCM
quoteType§EQUITY
shortName§Cyclo Therapeutics, Inc.
longName§Cyclo Therapeutics, Inc.
firstTradeDateEpochUtc§957360600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a5c907ad-6995-37ac-ac71-96d00d122983
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§0.318
grossMargins§0.90056
ebitdaMargins§0.0
trailingPegRatio§None
